Clinical Trials Directory

Trials / Unknown

UnknownNCT02761421

Effect of Motor Development, Motor Function and Electrophysiologic Findings of IOPD Under ERT

Effect of Motor Development, Motor Function and Electrodiagnostic Characteristic of IOPD Under ERT

Status
Unknown
Phase
Study type
Observational
Enrollment
15 (estimated)
Sponsor
Taipei Veterans General Hospital, Taiwan · Other Government
Sex
All
Age
Healthy volunteers
Not accepted

Summary

To investigate the motor development, motor function and electrodiagnostics presentation in IOPD under ERT.

Detailed description

Background Pompe disease is an autosomal recessive disease, enzyme replacement therapy (ERT) and new born screen (NBS) had been initiated in Taiwan since 2008. However, residual muscle weakness were noted. Decrease in amplitude of nerve compound muscle action potential (CMAP) and increase spontaneous activity were reported before the imitation of ERT. However, the motor development, motor function and electrodiagnostic presentation which were important in further direction of treatment and rehabilitation program arrangement in infantile Pompe disease (IOPD) under ERT is lacking. Aim To investigate the motor development, motor function and electrodiagnostic presentation in IOPD under ERT. Method This is an observational, prospective, longitudinal, follow-up study. Motor development was assessed by Alberta Infant Motor Scale (AIMS) and Peabody Developmental Motor Scales, Second Edition (PDMS II); motor function was assessed by Pediatric Evaluation of Disability Inventory (PEDI) and Gross Motor Function Measure (GMFM). Electrodiagnosis studies include nerve conduction study (NCS) and electromyography (EMG). Expect Effects Obtain the characteristics of motor development, motor function and electrodiagnosis presentation of IOPD under ERT, and the relation between motor development, motor function and electrodiagnosis presentation.

Conditions

Interventions

TypeNameDescription
OTHERobservation studyobservation study

Timeline

Start date
2016-01-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2016-05-04
Last updated
2016-05-04

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT02761421. Inclusion in this directory is not an endorsement.